Peter Karl Jacobsen

Preventing end stage renal disease in diabetic patients — genetic aspect (part I)
J Renin Angiotensin Aldosterone Syst 2005 6: 1-14. [Abstract] [PDF] [References]  

John L Reid

Review: Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?
J Renin Angiotensin Aldosterone Syst 2005 6: 15-24. [Abstract] [PDF] [References]  

The DIRECT Programme Study Group

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
J Renin Angiotensin Aldosterone Syst 2005 6: 25-32. [Abstract] [PDF] [References]  

Andrew J Boyle, Michael Schuster, Piotr Witkowski, Guosheng Xiang, Tetsunori Seki, Kerrie Way, and Silviu Itescu

Additive effects of endothelial progenitor cells combined with ACE inhibition and β-blockade on left ventricular function following acute myocardial infarction
J Renin Angiotensin Aldosterone Syst 2005 6: 33-37. [Abstract] [PDF] [References]  

Cevad Sekuri, F Sirri Cam, Ertugrul Ercan, Istemihan Tengiz, Abdi Sagcan, Erhan Eser, Afig Berdeli, and Mustafa Akin

Renin-angiotensin system gene polymorphisms and premature coronary heart disease
J Renin Angiotensin Aldosterone Syst 2005 6: 38-42. [Abstract] [PDF] [References]  

Nagesh S Anavekar and Scott D Solomon

Angiotensin II receptor blockade and ventricular remodelling
J Renin Angiotensin Aldosterone Syst 2005 6: 43-48. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.